On Helix 2024

We are thrilled to share that we will be showcasing our services at On Helix 2024 in Cambridge, UK! Join us at the Babraham Research Campus to explore how our offerings can support your Drug Discovery journey. We look forward…

Target to Patient

We are thrilled to share that we will be showcasing our services at Target to Patient Conference in Hinxton, UK. Join us at the Wellcome Genome Campus to discover how utilising CETSA® to confirm target engagement of candidate drugs can…

AACR 24

We’re thrilled to be at AACR24 in San Diego, showcasing our latest research with a strong presence through seven posters. We can’t wait to connect with you at our presentations. See below for where to find us! Review our 7…

Primary Screening Case Study

At Pelago Bioscience, we offer a high-throughput screening service based on CETSA® – a transformative, label-free assay for target engagement quantification in physiologically relevant contexts. This case study illustrates how employing high-throughput screening with CETSA can deliver…